GGrantIndex
Sort

40,608 grants matching prostate cancer

Nutiritional and Biochemical/Genetic Markers of Cancer

$737,484
Jing Ma · Brigham And Women'S Hospital · R01 · FY2006 · CA

Uncovering Causal Protein Markers to Characterize Pancreatic Cancer Etiology and Improve Risk Prediction

$737,444
Lang Wu · University Of Hawaii At Manoa · U01 · FY2024 · CA

BIOMARKER VALIDATION LABORATORIES

$737,284
University Of Alabama At Birmingham · U24 · FY2001 · CA

Core B: Recruitment and Sample Collection

$737,136
Ann S Hamilton · University Of Southern California · U19 · FY2022 · CA

Targeting mechanisms of radiation resistance

$737,084
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

MAP: a Flowable, Precision-Engineered, and Tunable Tissue Scaffold Leveraging Hyper-Porous Geometry to Control Inflammation and Promote Regenerative Healing in Diabetic Wounds

$737,053
Stephanie Deshayes · Tempo Therapeutics, Inc. · R44 · FY2019 · DK

Colorectal Tumor Risk Prediction in the PLCO Trial

$736,996
Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA

Genetic Predictors of Prostate Cancer Survival

$736,992
Robert J. Klein · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

Variation in tumor-associated immune profiles and colorectal cancer outcomes

$736,864
Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA

LIPID ELONGATION VIA ELOVL5: A NOVEL TARGET FOR ADVANCED PROSTATE CANCER...NEW GRANT, SIGNED 9/16/2019, EFFECTIVE 9/30/2019, DISTRIBUTED 9/17/2019, FAADC 9/17/2019

$736,816
Weill Medical College Of Cornell University · · FY2019 · Defense Health Agency

Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models

$736,797
Robert G Kalb · Northwestern University At Chicago · R01 · FY2024 · NS

SurvivorCare: A digital health solution to support long-term cancer survivorship using patient navigation

$736,762
Y. Xian Ho · Dimagi, Inc. · R44 · FY2022 · CA

GENETIC VARIATIONS IN MITOCHONDRIA AND PROSTATE CANCER AGGRESSIVENESS AND PROGRESSION IN CAUCASIAN AND AFRICAN AMERICAN MEN

$736,742
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2012 · Department of the Army

Molecular Analysis of Cancer--Imaging Mass Spectrometry

$736,634
Vanderbilt University · R33 · FY2004 · CA

Northwest Community Clinical Oncology Program

$736,536
Lauren Colman · Tacoma General Hospital · U10 · FY2009 · CA

Chicago Cancer Navigation Project

$736,516
Charles Lee Bennett · Northwestern University At Chicago · U01 · FY2008 · CA

GCDH Addiction in Melanoma

$736,400
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA

Tissue Array Research Program

$736,349
Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

PLCO Trial Etiologic and Early Marker Study

$736,077
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

Howard/Hopkins Cancer Centers Partnership

$736,068
Johns Hopkins University · U54 · FY2001 · CA

Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer

$735,974
Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2020 · CA

Nutritional and Biochemical/Genetic Markers of Cancer

$735,903
Brigham And Women'S Hospital · R01 · FY2005 · CA

RSI-AI: Predicting clinically significant prostate cancer to guide biopsy decisions by combining advanced tissue microstructure imaging with deep learning

$735,773
Nathan Scott White · Cortechs Labs, Inc. · R44 · FY2023 · CA

MS/AL Radiation Oncology Research Partnership

$735,602
Wiley Sam Dennis · Singing River Health System · U56 · FY2007 · CA

Consequences of retrotransposition on genome integrity

$735,574
Kathleen H Burns · Dana-Farber Cancer Inst · R01 · FY2025 · CA